A randomized cat study tested added meloxicam on top of alprazolam and phenoxybenzamine, leaving alprazolam’s independent effect unresolved.
Fifty-one male cats with obstructive idiopathic cystitis received the shared background regimen after discharge. Twenty-four also received low-dose meloxicam and 27 did not. No significant difference in recurrent obstruction was detected over six months, with a wide uncertainty interval.
Because both groups received alprazolam, recurrence rates do not establish whether it prevented obstruction. The trial was underpowered, and diet and other treatment varied. These are veterinary outcomes in cats, not evidence for human urinary or anxiety treatment. The paper illustrates a basic trial-reading distinction: a medicine listed in both arms is not automatically the intervention whose efficacy was tested. Claims about the shared benzodiazepine require a comparison capable of isolating it.
Original analysis of the supplied journal article, identified as PMC6766499.